Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Feb;64(2):212-6.
doi: 10.1001/archneur.64.2.212.

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease

Affiliations
Comparative Study

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease

Valerie Voon et al. Arch Neurol. 2007 Feb.

Abstract

Objective: To evaluate factors associated with pathological gambling (PG) in Parkinson disease (PD).

Design: Case-control study.

Setting: Outpatient tertiary clinic. Patients Twenty-one patients with idiopathic PD with PG after the patients began receiving medications compared with a consecutive sample of 42 patients with idiopathic PD without compulsive behaviors.

Main outcome measures: Clinical features, comorbid psychiatric and substance use disorders, personality traits, and impulsivity scores.

Results: Patients with PG had a younger age at PD onset (P = .006), higher novelty seeking (P<.001), medication-induced hypomania or mania (P = .001), impaired planning (P = .002), or a personal or immediate family history of alcohol use disorders (P = .002). Novelty seeking, a personal or immediate family history of alcohol use disorders, and younger age at PD onset accurately predicted PG at 83.7% in a logistic regression model, with the model accounting for 62% of the variance.

Conclusions: Patients with PD having a younger age at PD onset, higher novelty seeking traits, and a personal or family history of alcohol use disorders may have a greater risk for PG with dopamine agonists.

PubMed Disclaimer

Publication types

Substances